BCKDK
Basic information
Region (hg38): 16:31106107-31112791
Links
Phenotypes
GenCC
Source:
- branched-chain keto acid dehydrogenase kinase deficiency (Strong), mode of inheritance: AR
- branched-chain keto acid dehydrogenase kinase deficiency (Strong), mode of inheritance: AR
- branched-chain keto acid dehydrogenase kinase deficiency (Supportive), mode of inheritance: AR
- branched-chain keto acid dehydrogenase kinase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Branched-chain ketoacid dehydrogenase kinase deficiency | AR | Biochemical | Individuals may present with features such as autism, microcephaly, and epilepsy, and dietary management (eg, with high protein diet and branch-chain amino acid supplementation) has been shown to result in laboratory-based and clinical improvement | Biochemical; Dermatologic; Neurologic | 22956686; 36729635 |
ClinVar
This is a list of variants' phenotypes submitted to
- Branched-chain_keto_acid_dehydrogenase_kinase_deficiency (96 variants)
- Inborn_genetic_diseases (47 variants)
- not_provided (44 variants)
- not_specified (9 variants)
- BCKDK-related_disorder (8 variants)
- Maple_syrup_urine_disease,_mild_variant (1 variants)
- Maple_syrup_urine_disease_type_1A (1 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCKDK gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005881.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 37 | 40 | ||||
missense | 81 | 87 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 5 | 7 | 84 | 41 | 1 |
Highest pathogenic variant AF is 0.0000167285
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BCKDK | protein_coding | protein_coding | ENST00000394951 | 11 | 6683 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000566 | 0.974 | 125718 | 0 | 29 | 125747 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 209 | 287 | 0.728 | 0.0000204 | 2664 |
Missense in Polyphen | 56 | 100.07 | 0.5596 | 957 | ||
Synonymous | -0.181 | 124 | 121 | 1.02 | 0.00000865 | 868 |
Loss of Function | 2.00 | 10 | 19.6 | 0.511 | 9.17e-7 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000178 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000165 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.000165 | 0.000163 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation and inactivation of the branched-chain alpha-ketoacid dehydrogenase complex, the key regulatory enzyme of the valine, leucine and isoleucine catabolic pathways. Key enzyme that regulate the activity state of the BCKD complex. {ECO:0000269|PubMed:24449431}.;
- Disease
- DISEASE: Branched-chain ketoacid dehydrogenase kinase deficiency (BCKDKD) [MIM:614923]: A metabolic disorder characterized by autism, epilepsy, intellectual disability, and reduced branched- chain amino acids. {ECO:0000269|PubMed:22956686, ECO:0000269|PubMed:24449431}. Note=The disease is caused by mutations affecting the gene represented in this entry. A diet enriched in branched amino acids (BCAAs) allows to normalize plasma BCAA levels. This suggests that it may be possible to treat patients with mutations in BCKDK with BCAA supplementation.;
- Pathway
- Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.664
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.193
- hipred
- N
- hipred_score
- 0.464
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bckdk
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype;
Gene ontology
- Biological process
- protein phosphorylation;cellular amino acid catabolic process;branched-chain amino acid catabolic process;phosphorylation
- Cellular component
- mitochondrion;mitochondrial matrix;mitochondrial alpha-ketoglutarate dehydrogenase complex
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity